Afferent arteriolar vasodilation to the sulfonimide analog of 11, 12-epoxyeicosatrienoic acid involves protein kinase A.
- 1 January 1999
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 33 (1) , 408-413
- https://doi.org/10.1161/01.hyp.33.1.408
Abstract
Abstract —The current study determined the contribution of protein kinase-A (PKA) and protein kinase-G (PKG) to the vasodilation elicited by the N- methylsulfonimide analog of 11,12-epoxyeicosatrienoic acid (11,12-EET). Experiments were performed, in vitro, using the juxtamedullary nephron preparation combined with videomicroscopy. The response of afferent arterioles to the sulfonimide analog of 11,12-EET, was determined before and after inhibition of PKA, PKG, or guanylyl cyclase. Afferent arterioles, preconstricted with 0.5 μmol/L norepinephrine, averaged 18±1 μm (n=25) at a renal perfusion pressure of 100 mm Hg. Superfusion with 0.01 to 100 nmol/L of the 11,12-EET analog caused a graded increase in diameter of the afferent arteriole. Vessel diameter increased by 11±1% and 15±1%, respectively, in response to 10 and 100 nmol/L of the 11,12-EET analog. The afferent arteriolar response to 10 and 100 nmol/L of the 11,12-EET analog was significantly attenuated during inhibition of PKA with 10 μmol/L H-89 (n=7) or 5 μmol/L myristolated PKI (n=6), such that afferent arteriolar diameter increased by only 5±2% and 2±1%, respectively, in response to 100 nmol/L of the 11,12-EET analog. In contrast, the afferent arteriolar vasodilatory response to the 11,12-EET analog was unaffected by PKG or guanylyl cyclase inhibition. In the presence of 200 μmol/L histone H2B (n=5) or 10 μmol/L ODQ (n=7), the afferent arteriolar diameter increased by 16±3% and 12±2%, respectively, in response to 100 nmol/L of the 11,12-EET analog. These results demonstrate that activation of PKA is an important mechanism responsible for the afferent arteriolar vasodilation elicited by the sulfonimide analog of 11,12-EET.Keywords
This publication has 17 references indexed in Scilit:
- Cytochrome P450: a novel system modulating Ca2+ channels and contraction in mammalian heart cellsThe Journal of Physiology, 1998
- Epoxyeicosatrienoic acids, potassium channel blockers and endothelium‐dependent hyperpolarization in the guinea‐pig carotid arteryBritish Journal of Pharmacology, 1998
- Role of Cytochrome P-450 Enzymes and Metabolites of Arachidonic Acid in the Control of Vascular ToneJournal of Vascular Research, 1995
- Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet.Journal of Clinical Investigation, 1994
- Activation of K+ channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acidEuropean Journal of Pharmacology, 1993
- Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidneyBritish Journal of Pharmacology, 1992
- An epoxygenase metabolite of arachidonic acid mediates angiotensin II-induced rises in cytosolic calcium in rabbit proximal tubule epithelial cells.Journal of Clinical Investigation, 1991
- [40] Synthesis of epoxyeicosatrienoic acids and heteroatom analogsPublished by Elsevier ,1990
- Renal cytochrome P-450-dependent metabolism of arachidonic acid in spontaneously hypertensive ratsBiochemical Pharmacology, 1988
- Synthesis and biological activity of carboxyl-terminus modified prostaglandin analogsJournal of Medicinal Chemistry, 1979